Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER) long-term follow-up results from an open-label, randomised, phase 3 trial

DSpace Repositorium (Manakin basiert)

Zur Kurzanzeige

dc.contributor.author Bedke, Jens
dc.date.accessioned 2023-06-19T10:09:59Z
dc.date.available 2023-06-19T10:09:59Z
dc.date.issued 2022
dc.identifier.issn 1470-2045
dc.identifier.uri http://hdl.handle.net/10900/142281
dc.language.iso en de_DE
dc.publisher Elsevier Science Inc de_DE
dc.relation.uri http://dx.doi.org/10.1016/S1470-2045(22)00290-X de_DE
dc.subject.ddc 610 de_DE
dc.title Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER) long-term follow-up results from an open-label, randomised, phase 3 trial de_DE
dc.type Article de_DE
utue.quellen.id 20230202000000_02533
utue.publikation.seiten 888-898 de_DE
utue.personen.roh Motzer, Robert J.
utue.personen.roh Powles, Thomas
utue.personen.roh Burotto, Mauricio
utue.personen.roh Escudier, Bernard
utue.personen.roh Bourlon, Maria T.
utue.personen.roh Shah, Amishi Y.
utue.personen.roh Suarez, Cristina
utue.personen.roh Hamzaj, Alketa
utue.personen.roh Porta, Camillo
utue.personen.roh Hocking, Christopher M.
utue.personen.roh Kessler, Elizabeth R.
utue.personen.roh Gurney, Howard
utue.personen.roh Tomita, Yoshihiko
utue.personen.roh Bedke, Jens
utue.personen.roh Zhang, Joshua
utue.personen.roh Simsek, Burcin
utue.personen.roh Scheffold, Christian
utue.personen.roh Apolo, Andrea B.
utue.personen.roh Choueiri, Toni K.
dcterms.isPartOf.ZSTitelID Lancet Oncology de_DE
dcterms.isPartOf.ZS-Issue 7 de_DE
dcterms.isPartOf.ZS-Volume 23 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Dateien zu dieser Ressource

Dateien Größe Format Anzeige

Zu diesem Dokument gibt es keine Dateien.

Das Dokument erscheint in:

Zur Kurzanzeige